# Silvia Stacchiotti

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/silvia-stacchiotti/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,673 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 88 |
| i10-index | 248 |
| Last Known Institution | Dana-Farber Cancer Institute |
| OpenAlex ID | https://openalex.org/A5060954086 |
| ORCID iD | https://orcid.org/0000-0002-1742-8666 |
| Works | 668 |

## Researcher papers

- [Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice-guidelines-for/)
- [Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-genturis-clinical-practice/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-for/)
- [Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/bone-sarcomas-esmo-paedcan-euracan-clinical-practice-guidelines-for-diagnosis/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-genturis-clinical-practice/)
- [Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial](https://scholariq.org/papers/histotype-tailored-neoadjuvant-chemotherapy-versus-standard-chemotherapy-in/)
- [Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups](https://scholariq.org/papers/neoadjuvant-chemotherapy-in-high-risk-soft-tissue-sarcomas-final-results-of-a/)
- [Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group](https://scholariq.org/papers/management-of-primary-retroperitoneal-sarcoma-rps-in-the-adult-an-updated/)
- [Corrections to “Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”](https://scholariq.org/papers/corrections-to-soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice/)
- [Corrections to “Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”](https://scholariq.org/papers/corrections-to-gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Vascular Tumors and Angiosarcomas](https://scholariq.org/topics/vascular-tumors-and-angiosarcomas-2/)
- [Bone Tumor Diagnosis and Treatments](https://scholariq.org/topics/bone-tumor-diagnosis-and-treatments/)
- [Cardiac tumors and thrombi](https://scholariq.org/topics/cardiac-tumors-and-thrombi/)
- [Soft tissue tumor case studies](https://scholariq.org/topics/soft-tissue-tumor-case-studies/)

## Researcher university

- [Dana-Farber Cancer Institute](https://scholariq.org/institutions/dana-farber-cancer-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.